Action required to address growing risk of ‘biosimilars void’ ...Middle East

Data suggests that there is a lack of biosimilar medicines in development which would otherwise be predicted to launch in the years ahead. Market analysts believe this potential deficit constitutes a risk to patient access to affordable innovative treatments.

Read More Details
Finally We wish PressBee provided you with enough information of ( Action required to address growing risk of ‘biosimilars void’ )

Also on site :

• ‘She lit up the classroom’: First British victims of Air India plane crash named after 241 killed
• Increased ICE detentions and deportations create climate of fear and stress
• Numbrix 9 - June 13